SNSS - Sunesis Pharmaceuticals Inc
Previous close
13.5
0 0%
Share volume: 0
Last Updated: Thu 25 Feb 2021 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$13.50
0.00
0.00%
Summary score
31%
Profitability
38%
Dept financing
8%
Liquidity
27%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-93.28%
Return on assets
-27.7%
Return on sales
-2201.15%
Return on invested capital
80.66%
Total debt ratio
49.81%
Debt ratio change over timeo
-0.36%
Current Ratio
2.74%
Quick Ratio
0%
Cash Position Ratio
1.72%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-25.85%
Return on assets
-18.05%
Return on sales
0%
Return on invested capital
69.78%
Total debt ratio
28.78%
Debt ratio change over timeo
-0.59%
Current Ratio
3.59%
Quick Ratio
0%
Cash Position Ratio
2.5%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-39.67%
Return on assets
-24.88%
Return on sales
0%
Return on invested capital
72.95%
Total debt ratio
36.85%
Debt ratio change over time
-0.46%
Current Ratio
2.65%
Quick Ratio
0%
Cash Position Ratio
2.46%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-189.31%
Return on assets
-136.4%
Return on sales
-3550.54%
Return on invested capital
3.79%
Total debt ratio
-35.57%
Debt ratio change over time
-0.36%
Current Ratio
2.72%
Quick Ratio
0%
Cash Position Ratio
1.52%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SNSS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -93.28% | 0% | 0% | 29.06% |
| Return on assets | -27.7% | 0% | 0% | -9.75% |
| Return on sales | -2201.15% | 0% | 0% | -1469.44% |
| Return on invested capital | 80.66% | 0% | 0% | 47.78% |
| Profitability | 25% | 0% | 50% | 40% |
| Total debt ratio | 49.81% | 0% | 0% | 183.15% |
| Debt ratio change over time | -0.36% | 0% | 0% | 19.02% |
| Dept financing | 7% | 0% | 0% | 50% |
| Current Ratio | 3.59% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.5% | 0% | 0% | 5.68% |
| Liquididy | 28% | 0% | 0% | 75% |
| Short-term ratios | SNSS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -25.85% | 0% | 0% | -16.12% |
| Return on assets | -18.05% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | 69.78% | 0% | 0% | 96.56% |
| Profitability | 43% | 0% | 50% | 25% |
| Total debt ratio | 28.78% | 0% | 0% | 79.61% |
| Debt ratio change over time | -0.59% | 0% | 0% | 0.09% |
| Dept financing | 9% | 0% | 0% | 50% |
| Current Ratio | 3.59% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.5% | 0% | 0% | 5.68% |
| Liquididy | 26% | 0% | 0% | 75% |